BeOne Medicines AG (6160.HK) HKSE
168.20
-0.6(-0.36%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
168.20
-0.6(-0.36%)
Currency In HKD
Address
Aeschengraben 27
Basel, MA 4051
Switzerland
Phone
41 61 685 19 00
Website
Sector
Healthcare
Industry
Biotechnology
Employees
11000
First IPO Date
August 08, 2018
| Name | Title | Pay | Year Born |
| John V. Oyler | Co-Founder, Executive Chairman & Chief Executive Officer | 23.07M | 1968 |
| Chan Lee | General Counsel, Senior VP & Corporate Secretary | 9.84M | 1968 |
| Aaron Rosenberg | Chief Financial Officer | 9.93M | 1977 |
| Wang Lai | President and Global Head of Research & Development | 10.34M | 1978 |
| Xiaodong Wang | Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | 33.31M | 1963 |
| Titus Ball | Vice President & Chief Accounting Officer | 0 | 1974 |
| Graham Hardiman | Global Head of Human Resources | 0 | N/A |
| Eleanor Duff | Senior Vice President & Head of Corporate Communications | 0 | N/A |
| Liza Heapes | Head of Investor Relations | 0 | N/A |
| Mark Lanasa | Senior Vice President & Chief Medical Officer for Solid Tumors | 0 | N/A |
| Marcello Damiani | Chief Technology Officer | 0 | 1970 |
BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.